Skinvisible (SKVI) Invested Capital (2011 - 2026)

Skinvisible has disclosed Invested Capital across 16 years of filings, most recently posting -$5.3 million for Q2 2026.

• In Q2 2026, Invested Capital fell 31.57% year-over-year to -$5.3 million; the TTM figure through Jun 2026 stood at -$5.3 million (down 31.57% YoY), while the FY2025 annual figure was -$4.5 million, down 17.08% from the prior year.
• Invested Capital came in at -$5.3 million for Q2 2026 at Skinvisible, down from -$5.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$656317.0 in Q4 2022 to a low of -$5.3 million in Q2 2026.
• Average Invested Capital over 5 years is -$3.5 million, with a median of -$3.7 million recorded in 2023.
• Year-over-year, Invested Capital surged 74.76% in 2022 and tumbled 449.22% in 2023.
• Over 5 years, Invested Capital stood at -$656317.0 in 2022, then plunged by 449.22% to -$3.6 million in 2023, then dropped by 6.47% to -$3.8 million in 2024, then slipped by 17.08% to -$4.5 million in 2025, then fell by 17.61% to -$5.3 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were -$5.3 million in Q2 2026, -$5.1 million in Q1 2026, and -$4.5 million in Q4 2025.